Neuland Laboratories Ltd

NEULANDLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,172 cr, stock is ranked 700
High RiskStock is 3.47x as volatile as Nifty
1,746.7553.25 (+3.14%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,172 cr, stock is ranked 700
High RiskStock is 3.47x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
26.95
PB RatioPB Ratio
2.76
Dividend YieldDiv. Yield
0.18%
Sector PESector PE
38.41
Sector PBSector PB
5.14
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

33%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Neuland Laboratories Limited is engaged in manufacturing active pharmaceutical ingredient (API). The Company also provides custom manufacturing solutions (CMS) to develop and manufacture pharmaceutical ingredients and intermediates.

Investor PresentationView older 

Oct 29, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021531.94670.32766.60953.0112.0616.4416.2180.63
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss of Share Certificates 
Announced OnNov 29, 2021

Neuland Laboratories Limited has informed the Exchange about Loss of Share Certificates | Download

Neuland Laboratories Limited has informed the Exchange about Loss of Share Certificates | Download

Updates 
Announced OnNov 24, 2021

Neuland Laboratories Limited has informed the Exchange regarding 'Intimation of Submission of Application to Stock Exchanges for Reclassification of "Promoter/ Promoter Group" shareholders to "Public" shareholders'. | Download

Neuland Laboratories Limited has informed the Exchange regarding 'Intimation of Submission of Application to Stock Exchanges for Reclassification of "Promoter/ Promoter Group" shareholders to "Public" shareholders'. | Download

Cash Dividend 
Ex. DateJun 29, 2021

Final • Div/Share: ₹ 3

See all events